Olivia Ferrández

846 total citations
36 papers, 596 citations indexed

About

Olivia Ferrández is a scholar working on Geriatrics and Gerontology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Olivia Ferrández has authored 36 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Geriatrics and Gerontology, 11 papers in Infectious Diseases and 8 papers in Epidemiology. Recurrent topics in Olivia Ferrández's work include Pharmaceutical Practices and Patient Outcomes (13 papers), Antibiotic Use and Resistance (5 papers) and Pharmacovigilance and Adverse Drug Reactions (5 papers). Olivia Ferrández is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (13 papers), Antibiotic Use and Resistance (5 papers) and Pharmacovigilance and Adverse Drug Reactions (5 papers). Olivia Ferrández collaborates with scholars based in Spain, Australia and United States. Olivia Ferrández's co-authors include Santiago Grau, Juan Pablo Horcajada, Daniel Echeverría-Esnal, Clara Martín‐Ontiyuelo, E. Salas, Sònia Luque, Sergi Mojal, Merçè Espona, Marta Riu and Xavier Durán and has published in prestigious journals such as International Journal of Environmental Research and Public Health, Clinical Microbiology and Infection and Frontiers in Pharmacology.

In The Last Decade

Olivia Ferrández

32 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olivia Ferrández Spain 11 234 119 108 103 77 36 596
Afsaneh Vazin Iran 17 194 0.8× 91 0.8× 111 1.0× 61 0.6× 107 1.4× 70 788
Nathalie Asseray France 18 262 1.1× 121 1.0× 244 2.3× 67 0.7× 104 1.4× 52 889
Mansour Tobaiqy Saudi Arabia 14 319 1.4× 92 0.8× 77 0.7× 38 0.4× 66 0.9× 41 859
Nirmeen A. Sabry Egypt 16 84 0.4× 146 1.2× 205 1.9× 108 1.0× 63 0.8× 70 973
Abdullah A. Alhifany Saudi Arabia 15 159 0.7× 74 0.6× 69 0.6× 66 0.6× 57 0.7× 61 553
Sonal Sekhar Miraj India 17 164 0.7× 115 1.0× 115 1.1× 40 0.4× 36 0.5× 67 805
Saleh Alghamdi Saudi Arabia 16 188 0.8× 68 0.6× 114 1.1× 150 1.5× 36 0.5× 63 716
Samar Farid Egypt 14 80 0.3× 131 1.1× 96 0.9× 104 1.0× 28 0.4× 51 602
George Delgado United States 10 176 0.8× 127 1.1× 197 1.8× 45 0.4× 106 1.4× 17 754
Rachel M. Kenney United States 15 220 0.9× 43 0.4× 230 2.1× 175 1.7× 153 2.0× 74 805

Countries citing papers authored by Olivia Ferrández

Since Specialization
Citations

This map shows the geographic impact of Olivia Ferrández's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivia Ferrández with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivia Ferrández more than expected).

Fields of papers citing papers by Olivia Ferrández

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivia Ferrández. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivia Ferrández. The network helps show where Olivia Ferrández may publish in the future.

Co-authorship network of co-authors of Olivia Ferrández

This figure shows the co-authorship network connecting the top 25 collaborators of Olivia Ferrández. A scholar is included among the top collaborators of Olivia Ferrández based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivia Ferrández. Olivia Ferrández is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Herranz, Susana, Daniel Sevilla‐Sánchez, R. Jordana, et al.. (2024). Multidisciplinary medication review during older patient hospitalization according to STOPP/START criteria reduces potentially inappropriate prescriptions: MoPIM cohort study. BMC Geriatrics. 24(1). 584–584. 1 indexed citations
3.
Baré, Marisa, Daniel Sevilla‐Sánchez, Susana Herranz, et al.. (2023). Sex Differences in Multimorbidity, Inappropriate Medication and Adverse Outcomes of Inpatient Care: MoPIM Cohort Study. International Journal of Environmental Research and Public Health. 20(4). 3639–3639. 3 indexed citations
4.
Echeverría-Esnal, Daniel, Luisa Sorlí, Robert Güerri‐Fernández, et al.. (2022). Antibiotic desensitization as a potential tool in antimicrobial stewardship programs: retrospective data analysis and systematic literature review. Expert Review of Anti-infective Therapy. 20(11). 1491–1500. 2 indexed citations
5.
López-Montesinos, Inmaculada, Juan Du, Esperanza Cañas‐Ruano, et al.. (2022). Comparative Analysis of Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa and Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae. Antibiotics. 11(11). 1511–1511. 3 indexed citations
6.
Echeverría-Esnal, Daniel, Sònia Luque, Laia Domingo, et al.. (2022). Drug-related problems in patients admitted for SARS-CoV-2 infection during the COVID-19 pandemic. Frontiers in Pharmacology. 13. 993158–993158. 2 indexed citations
7.
Espona, Merçè, Daniel Echeverría-Esnal, Sergi Hernández, et al.. (2021). Impact of Generic Entry on Hospital Antimicrobial Use: A Retrospective Quasi-Experimental Interrupted Time Series Analysis. Antibiotics. 10(10). 1149–1149.
8.
Grau, Santiago, Daniel Echeverría-Esnal, Sílvia Gómez-Zorrilla, et al.. (2021). Evolution of Antimicrobial Consumption During the First Wave of COVID-19 Pandemic. Antibiotics. 10(2). 132–132. 70 indexed citations
9.
Echeverría-Esnal, Daniel, et al.. (2021). Pharmacological management of antifungal agents in pulmonary aspergillosis: an updated review. Expert Review of Anti-infective Therapy. 20(2). 179–197. 10 indexed citations
10.
Grau, Santiago, Olivia Ferrández, Elena Martín‐García, & Rafaël Maldonado. (2021). Reconstituted mRNA COVID-19 vaccines may maintain stability after continuous movement. Clinical Microbiology and Infection. 27(11). 1698.e1–1698.e4. 7 indexed citations
11.
Ferrández, Olivia, Xavier Durán, Carolina Pérez-García, et al.. (2021). Impact of Non-Persistence on Healthcare Resource Utilization and Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study. Frontiers in Pharmacology. 12. 752879–752879. 5 indexed citations
12.
13.
Ferrández, Olivia, et al.. (2018). Validation of a score to identify inpatients at risk of a drug-related problem during a 4-year period. Saudi Pharmaceutical Journal. 26(5). 703–708. 11 indexed citations
14.
Ferrández, Olivia, et al.. (2016). Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections. Drug Design Development and Therapy. Volume11. 65–82. 19 indexed citations
15.
Luque, Sònia, Santiago Grau, Francisco Álvarez-Lerma, et al.. (2014). Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections. International Journal of Antimicrobial Agents. 44(5). 409–415. 51 indexed citations
16.
Ferrández, Olivia, Sònia Luque, Santiago Grau, et al.. (2014). Patient risk factors for developing a drug-related problem in a cardiology ward. Therapeutics and Clinical Risk Management. 11. 9–9. 37 indexed citations
17.
Ferrández, Olivia, et al.. (2013). Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections. Drug Design Development and Therapy. 7. 243–243. 21 indexed citations
18.
Ferrández, Olivia, et al.. (2012). Long-term treatment with linezolid in a patient with osteomyelitis undergoing hemodialysis. Journal of Chemotherapy. 24(4). 226–228. 3 indexed citations
19.
Ferrández, Olivia, Santiago Grau, Pere Saballs, et al.. (2011). Factores de riesgo de mortalidad en pacientes con bacteriemia por cepas productoras de betalactamasas de espectro extendido. Revista Clínica Española. 211(3). 119–126. 7 indexed citations
20.
Schröder, Helmut, Olivia Ferrández, Jordi Jiménez Conde, Albert Sánchez‐Font, & Jaume Marrugat. (2005). Cardiovascular Risk Profile and Type of Alcohol Beverage Consumption: A Population-Based Study. Annals of Nutrition and Metabolism. 49(2). 100–106. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Afsaneh Vazin Breakdown of academic impact, for papers by Nathalie Asseray Breakdown of academic impact, for papers by Mansour Tobaiqy Breakdown of academic impact, for papers by Nirmeen A. Sabry Breakdown of academic impact, for papers by Abdullah A. Alhifany Breakdown of academic impact, for papers by Sonal Sekhar Miraj Breakdown of academic impact, for papers by Saleh Alghamdi Breakdown of academic impact, for papers by Samar Farid Breakdown of academic impact, for papers by George Delgado Breakdown of academic impact, for papers by Rachel M. Kenney
Rankless by CCL
2026